GlobeNewsWire
14 Jun 2026, 16:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
A class action lawsuit has been filed against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) alleging violations of federal securities laws. — Securities fraud litigation creates significant legal uncertainty and potential financial liabilities for the company.
-0.60The lawsuit alleges that Regencell and its officers made materially false and misleading statements regarding business operations and compliance policies between October 28, 2024, and October 31, 2025. — Claims of operational dishonesty and compliance failures undermine investor trust in the company's reported fundamentals.
-0.40Which stocks this story touches
The company is the subject of a new class action lawsuit alleging securities fraud violations.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a class action lawsuit alleging materially false and misleading statements and securities law violations.
The company is the subject of a new class action lawsuit alleging securities fraud violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
